Alambatin, Alice M.

HRN: 02-24-04  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/06/2023
11/12/2023
IVT
4.5gms
Q8
Complicated UTI, DM Type2
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: